Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807907 · ClinicalTrials.gov registry record · NA
Promoting Infant-Directed Speech in Ghana
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 2,800
- Enrollment target
NCT04807907 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 2,800 participants.
The verdict
NCT04807907, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,800 participants
- Enrollment target
Study Summary
The study is a randomized evaluation of a low-cost intervention that encourages mothers and other caregivers to talk to infants, or to engage in what is known as infant-directed speech (IDS) as a way of promoting language and brain development in Tamale and surrounding areas, Ghana.
Interventions
- BEHAVIORAL Infant Directed Speech (IDS) Video + IDS Wall Calendar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04807907
The ClinicalTrials.gov registry entry for NCT04807907 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Infant Directed Speech (IDS) Video + IDS Wall Calendar is the first listed.
NCT04807907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04807907 about?
NCT04807907 is a clinical study titled "Promoting Infant-Directed Speech in Ghana". The study is a randomized evaluation of a low-cost intervention that encourages mothers and other caregivers to talk to infants, or to engage in what is known as infant-directed speech (IDS) as a way of promoting language and brain development in Tamale and surrounding areas, Ghana.
What is the current status of trial NCT04807907?
This trial is currently completed. It is a NA study. The enrollment target is 2,800 participants. The study started on 2021-03-02. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT04807907?
The interventions under investigation include: Infant Directed Speech (IDS) Video + IDS Wall Calendar (BEHAVIORAL).
Who is sponsoring clinical trial NCT04807907?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.